Involvement of the Contralesional Angiotensin Type 2 Receptor in Compound 21 Mediated Functional Recovery After Stroke

被引：0
|
作者：
Fouda, Abdelrahman Y. [1 ]
Ishrat, Tauheed [1 ]
Ahmed, Heba [1 ]
Pillai, Bindu [1 ]
Artham, Andeep [1 ]
Ergul, Adviye [1 ]
Fagan, Susan [1 ]
机构：
[1] Univ Georgia, Clin & Adm Pharm, Augusta, GA USA
来源：
STROKE | 2016年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WP101
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy
    Porrello, Enzo R.
    D'Amore, Angelo
    Curl, Claire L.
    Allen, Andrew M.
    Harrap, Stephen B.
    Thomas, Walter G.
    Delbridge, Lea M. D.
    HYPERTENSION, 2009, 53 (06) : 1032 - 1040
  • [32] Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease
    Chisholm, Jessica
    Gareau, Alison J.
    Byun, Stephanie
    Paletz, Justin L.
    Tang, David
    Williams, Jason
    LeVatte, Terry
    Bezuhly, Michael
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 140 (05) : 686E - 696E
  • [33] Effect of Compound 21-A Selective Angiotensin II Type 2 Receptor Agonist in an Abdominal Adhesion Murine Model
    Boudreau, C. G.
    Levatte, T.
    Gareau, A.
    Legere, S.
    Bezuhly, M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S171 - S171
  • [34] Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
    Verdonk, Koen
    Durik, Matej
    Abd-Alla, Nalina
    Batenburg, Wendy W.
    van den Bogaerdt, Antoon J.
    van Veghel, Richard
    Roks, Anton J. M.
    Danser, A. H. Jan
    van Esch, Joep H. M.
    HYPERTENSION, 2012, 60 (03) : 722 - 729
  • [35] Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
    Menk, Mario
    Graw, Jan Adriaan
    von Haefen, Clarissa
    Steinkraus, Hendrik
    Lachmann, Burkhard
    Spies, Claudia D.
    Schwaiberger, David
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 169 - 178
  • [36] Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
    van Esch, Joep H.
    Verdonk, Koen
    Batenburg, Wendy W.
    Moltzer, Els
    van Veghel, Richard
    Unger, Thomas
    Steckelings, Ulrike M.
    Danser, A. H. Jan
    HYPERTENSION, 2011, 58 (05) : E96 - E96
  • [37] Diabetes mellitus type 2 impedes functional recovery, neuroplasticity and quality of life after stroke
    Chaturvedi, Poonam
    Singh, Ajai Kumar
    Tiwari, Vandana
    Thacker, Anup Kumar
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 1035 - 1041
  • [38] CEREBROPROTECTIVE EFFECT OF AN ANGIOTENSIN TYPE 2 RECEPTOR AGONIST DELIVERED VIA THE INTRANASAL ROUTE AFTER STROKE
    Sumners, C.
    Bennion, D.
    Jones, C.
    Dang, A.
    Isenberg, J.
    Graham, J.
    Waters, M.
    Steckelings, U.
    JOURNAL OF HYPERTENSION, 2017, 35 : E6 - E6
  • [39] Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats
    McCarthy, Claudia A.
    Vinh, Antony
    Broughton, Brad R. S.
    Sobey, Christopher G.
    Callaway, Jennifer K.
    Widdop, Robert E.
    HYPERTENSION, 2012, 60 (06) : 1531 - U396
  • [40] Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential
    Unger, Thomas
    Dahlof, Bjorn
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 75 - 77
12345